Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Treatment of lipid metabolic disorders using 5-(1,2-dithiolan-3-yl) valeric acid (&agr;-lipoic acid) or its physiologically compatible salts

Treatment of lipid metabolic disorders using 5-(1,2-dithiolan-3-yl) valeric acid (&agr;-lipoic acid) or its physiologically compatible salts

US Patent 6518300 · Granted Feb 11, 2003

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Deuterated catecholamine derivatives and medicaments compromising said compounds2017
Position-specific asymmetric deuterium enriched catecholamine derivatives and me2017
Deuterated catecholamine derivatives and medicaments comprising said compounds2017
Position-specific asymmetric deuterium enriched catecholamine derivatives and me2017
Deuterated catecholamine derivatives and medicaments comprising said compounds2012
Deuterated catecholamine derivatives and medicaments comprising said compounds2012
Use of a medicament containing an effector of the glutathione metabolism togethe2009
Use of a medicament containing an effector of the glutathione metabolism togethe2009
Medicament containing an effector of the glutathione metabolism together with α-2008
Medicament containing an effector of the glutathione metabolism together with α-2008
Deuterated substituted dihydrofuranones and medicaments containing these compoun2008
Hyaluronate lyase used for promoting penetration in topical agents2004